Is it safe to restart birth control (combined oral contraceptive) therapy in a patient with elevated prolactin levels and recurrent acne?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Combined Oral Contraceptives for Acne in a Patient with Elevated Prolactin

Combined oral contraceptives (COCs) can be safely restarted in a patient with mildly elevated prolactin (36 ng/mL) and recurrent acne, as this level is only slightly above normal range and does not necessarily indicate a clinically significant pituitary microadenoma requiring treatment before COC initiation.

Understanding the Relationship Between Prolactin, Acne, and COCs

Prolactin and Acne Connection

  • Hyperprolactinemia can be a contributing factor to acne development and persistence 1
  • A level of 36 ng/mL represents mild elevation (normal range typically <25 ng/mL)
  • Research has shown that treating hyperprolactinemia can improve acne in patients with idiopathic hyperprolactinemia 2

COCs and Acne Treatment

  • COCs are effective in treating acne by:
    • Increasing estrogen levels and sex hormone-binding globulins
    • Decreasing free testosterone and androgen levels 3
  • The American Academy of Dermatology recommends hormonal therapy (including COCs) for hormonal acne with moderate strength of evidence 4

COC Selection for Acne Management

Most Effective COCs for Acne

  • Drospirenone-containing COCs are recommended as the most effective for treating acne due to their anti-androgenic properties 4
  • A hierarchy of effectiveness based on progestin component:
    • Drospirenone (most helpful) > norgestimate and desogestrel > levonorgestrel and norethindrone 5
  • COCs containing chlormadinone acetate or cyproterone acetate may be more effective than those with levonorgestrel 6

Management Algorithm for This Patient

  1. Confirm prolactin elevation is mild and isolated

    • Rule out medication causes (antipsychotics, some antidepressants)
    • Ensure no galactorrhea, visual changes, or headaches that would suggest a more concerning pituitary lesion
  2. Select appropriate COC formulation

    • Choose a drospirenone-containing COC as first choice
    • Alternatives include COCs with norgestimate or desogestrel
  3. Monitor for potential issues

    • Follow up in 3 months to assess:
      • Acne improvement
      • Any symptoms of worsening hyperprolactinemia
      • Repeat prolactin level if symptoms develop
  4. Patient education

    • Advise that COCs may take 3-6 months to show maximum benefit for acne
    • Instruct on proper pill usage to maintain effectiveness:
      • Take at same time daily
      • If one pill is missed (<24 hours), take immediately and continue regular schedule
      • If two or more pills are missed (≥48 hours), use backup contraception for 7 days 7

Important Considerations and Caveats

  • Mild hyperprolactinemia alone is not a contraindication to COC use in the absence of a diagnosed pituitary adenoma
  • Monitoring is important as some research suggests a relationship between prolactin levels and hormonal symptoms
  • Avoid estrogen-containing contraceptives in patients with confirmed pituitary macroadenomas due to theoretical risk of tumor growth
  • If prolactin levels continue to rise significantly or symptoms develop, consider referral to endocrinology for further evaluation

By restarting COCs with appropriate monitoring, you can effectively manage this patient's recurrent acne while maintaining vigilance regarding her mildly elevated prolactin level.

References

Guideline

Acne Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Combined oral contraceptive pills for treatment of acne.

The Cochrane database of systematic reviews, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.